THRESA MYERS: Open Payments
NPI 1548820335 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 44 payments from 17 companies in 2025. Trend: 2023 $476 · 2024 $1,208 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $132 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $118 |
| Sumitomo Pharma America, Inc. | 1 | $78 |
| Lilly USA, LLC | 5 | $78 |
| Exact Sciences Corporation | 2 | $35 |
| Boston Scientific Corporation | 1 | $35 |
| ABBVIE INC. | 2 | $28 |
| Gilead Sciences, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
Products named: OTEZLA, Kerendia, CAPLYTA, GEMTESA, MOUNJARO, Cologuard Collection Kit, WATCHMAN, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
